Where patients already are.
PhaseWell sites are rooted in the communities they serve, led by trusted local investigators.
Access starts with a relationship.
The most valuable patient populations aren't simply identified. They're cared for.
Across our sites, patients are connected to research through physicians who already understand their medical history, disease progression, and treatment journey. These established relationships create opportunities to identify appropriate participants earlier and support stronger retention throughout the life of a study.
For sponsors, that translates into more meaningful patient access, stronger engagement, and research that is integrated into real-world clinical care.
Geography is a performance advantage.
When a site sits in the community a patient already lives, enrollment moves faster and patients stay through the end of the study.
Proximity isn't a convenience. It's what keeps enrollment and retention on track, because for over 19 million potential participants, the right site is already nearby.
Looking into a trial for yourself or someone you love?
If you're a patient or caregiver, you're in the right place. PhaseWell sites run clinical trials in communities across the country, often through the kind of physicians you already see.
The access advantage starts with a feasibility conversation.
